Open now. The Delaware Community Foundation is accepting applications for the Borkee Hagley Foundation Grant Fund, a statewide opportunity supporting clinical research, care, and social and emotional support for the comprehensive and complex care of patients and families affected by neurodegenerative diseases, including Huntington’s disease, ALS, Parkinson’s disease, and Alzheimer’s.
Deadline and funding
DCF’s current 2026 grants page says the opportunity opened August 10, 2026 and closes October 16, 2026. The current public page does not publish a clock time or time zone, so Atlas does not invent one.
DCF’s current page links to an application PDF labeled “2025 Borkee Hagley Fund Grant Process,” which states that the maximum request is $50,000. Because the linked form carries a 2025 title, applicants should confirm the $50,000 ceiling inside the live 2026 grant portal before final submission.
Eligibility and application controls
DCF’s general grant eligibility requires grantees to serve Delaware and its residents and excludes individuals and non-501(c)(3) nonprofit organizations. General exclusions also include standard office equipment and office operating expenses such as ordinary website services, software, desktop/laptop computers and office phone systems; vehicles; public or tuition-based educational institutions; endowment; debt reduction; annual fundraising campaigns; and special events. Each DCF grant can also have its own program-specific requirements.
Applications are submitted through the DCF online grant portal. No mandatory non-Federal match or cost share is stated in the current public Borkee Hagley listing or the currently linked application material reviewed by Atlas.
Atlas strategy
Atlas Opportunity Score: 94/100. This is a highly targeted Delaware healthcare and patient-support funding vehicle with strong relevance to organizations serving people with Alzheimer’s, ALS, Parkinson’s, Huntington’s and related neurodegenerative conditions.
N9+ Fit: 45/100, conditional. A legitimate connected-care or remote physical-examination role may exist for an eligible nonprofit clinical program if the live 2026 portal permits the specific technology cost and the use directly advances neurodegenerative-disease care. Atlas will not assume equipment or platform allowability from the broad program description. For primarily education/support organizations, N9+ should not be forced into the request.
QC Healthcare Fit: 20/100, conditional. A services role would require both a clinically appropriate applicant program and verified allowability of contracted clinical services.
Direct Dr. Miltie posture: not eligible as the grant applicant under DCF’s published general 501(c)(3) requirement. The appropriate path is an eligible Delaware nonprofit applicant, with Dr. Miltie involved only when the applicant’s program and current DCF budget rules support a legitimate role.
Next action
Eligible Delaware neurodegenerative-disease organizations should confirm the live portal’s 2026 funding ceiling and program-specific budget rules, define the Delaware patient/family population and requested program, and submit through DCF’s grant portal before October 16, 2026.
Official source: Delaware Community Foundation current grant opportunities.
Current linked application material: Borkee Hagley application PDF.